Hotchkis & Wiley Capital Management’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
Other funds holding CLB
AI
DGI
CAMG
Hotchkis & Wiley Capital Management's CLB Position: Q2 2026 in Review
Hotchkis & Wiley Capital Management increased its Core Laboratories (CLB) stake by 30% in Q2 2026, buying an estimated $783K and bringing the position to 235,015 shares worth $2.74M. The position accounts for 0.01% of the portfolio, ranked #442.
Hotchkis & Wiley Capital Management first reported a position in CLB in Q4 2020 and has held it in 15 quarters since. The position peaked at $8.83M in Q4 2025. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.
- Hotchkis & Wiley Capital Management held 235,015 shares of Core Laboratories worth $2.74M as of Q2 2026.
- Hotchkis & Wiley Capital Management bought 54,880 Core Laboratories shares in Q2 2026, an estimated $783K.
- Core Laboratories made up 0.01% of Hotchkis & Wiley Capital Management's portfolio in Q2 2026, its #442 holding.
- Hotchkis & Wiley Capital Management first reported a position in Core Laboratories in Q4 2020 and has held it in 15 quarters since.
- Hotchkis & Wiley Capital Management's Core Laboratories position peaked at $8.83M in Q4 2025.
- 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.
Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.